Healthcare & Life Sciences
Eidos Therapeutics
United States
series-b
series-b
Stage
1
Investors
About
Eidos Therapeutics is a biopharmaceutical company developing precision medicines for genetically defined, debilitating transthyretin amyloidosis.
Explore Eidos Therapeutics's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.